4//SEC Filing
Molecular Insight Pharmaceuticals, Inc. 4
Accession 0001209191-07-067599
CIK 0001340752operating
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 3:59 PM ET
Size
11.2 KB
Accession
0001209191-07-067599
Insider Transaction Report
Form 4
LaFrance Norman D.
Sr. VP Clinical Dev and CMO
Transactions
- Purchase
Common Stock
2007-11-30$8.75/sh+100$875→ 2,100 total - Purchase
Common Stock
2007-11-30$8.78/sh+1,900$16,682→ 4,000 total
Issuer
Molecular Insight Pharmaceuticals, Inc.
CIK 0001340752
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0001340752
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 3:59 PM ET
- Size
- 11.2 KB